Anti-HCV DAA are needed whatever liver fibrosis is. The cons
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020312371 |
id |
doaj-b627c5e597464ced9939a9a4038b46a7 |
---|---|
record_format |
Article |
spelling |
doaj-b627c5e597464ced9939a9a4038b46a72021-05-04T07:25:03ZengElsevierJournal of Virus Eradication2055-66402016-05-0125Anti-HCV DAA are needed whatever liver fibrosis is. The consPablo Barreiro0La Paz University Hospital, Madrid, Spainhttp://www.sciencedirect.com/science/article/pii/S2055664020312371 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pablo Barreiro |
spellingShingle |
Pablo Barreiro Anti-HCV DAA are needed whatever liver fibrosis is. The cons Journal of Virus Eradication |
author_facet |
Pablo Barreiro |
author_sort |
Pablo Barreiro |
title |
Anti-HCV DAA are needed whatever liver fibrosis is. The cons |
title_short |
Anti-HCV DAA are needed whatever liver fibrosis is. The cons |
title_full |
Anti-HCV DAA are needed whatever liver fibrosis is. The cons |
title_fullStr |
Anti-HCV DAA are needed whatever liver fibrosis is. The cons |
title_full_unstemmed |
Anti-HCV DAA are needed whatever liver fibrosis is. The cons |
title_sort |
anti-hcv daa are needed whatever liver fibrosis is. the cons |
publisher |
Elsevier |
series |
Journal of Virus Eradication |
issn |
2055-6640 |
publishDate |
2016-05-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2055664020312371 |
work_keys_str_mv |
AT pablobarreiro antihcvdaaareneededwhateverliverfibrosisisthecons |
_version_ |
1721479914590306304 |